SEBI has cleared MakeMyTrip's Indian operating company to go public. The regulator issued its final observations on 6 November 2026 and the update appeared on its website on 9 November, according to a PTI report. Two things make this listing unusual. MakeMyTrip has been listed on Nasdaq for over a decade and a half, so this is a company already public in the US floating its Indian arm at home. And the shares on offer are being sold by the parent and its Singapore subsidiary, so the Indian company itself raises nothing. For founders weighing where to list, and why, it's a useful live case study.
What exactly SEBI approved
Per the PTI report carried by The Federal, MakeMyTrip (India) Ltd filed its draft papers in July through SEBI's confidential route. The IPO will involve a sale of shares by the Nasdaq-listed parent, MakeMyTrip, and its wholly owned subsidiary, ibibo Group Holdings (Singapore). After listing, the Indian company stays a subsidiary and its results continue to be consolidated with the parent's.
Outlook Business reported in July that the pre-filed draft went to SEBI, BSE and NSE on 17 July, and that no fresh shares are being issued. The size hasn't been disclosed. Reports of a $1 billion-plus issue are estimates, not numbers from the company.
An all-OFS IPO pays the sellers, not the company
Most startup IPOs mix two things. A fresh issue creates new shares, and the money goes into the company to build things. An offer for sale (OFS) lets existing shareholders sell some of what they own, and the money goes to them.
MakeMyTrip's India IPO is the second kind. So the useful question isn't "what will MMT India build with the money?" It's "what does the parent want the cash for?" The company has answered that publicly: the proceeds should strengthen the parent's cash position, to be used for long-term growth, "strategic inorganic initiatives" and repurchases of its securities, including convertible securities.
That's a holding-company use of an IPO. It turns part of a stake in a fast-growing Indian business into cash at the group level, at a price set by Indian investors.
Why list the Indian arm at all?
The company's stated reasons, from its filings as reported, are fairly plain:
Brand visibility in its home market.
Talent: a listing should help MMT India "attract, incentivise and retain talent" in a competitive tech hiring market.
Optionality: MakeMyTrip has said it may look at a security that is "fungible and listed across both Indian and US capital markets," subject to regulatory approval.
Read between the lines and there's a simpler commercial logic. MakeMyTrip's customers, employees and most of its competitors are Indian. Indian public markets have shown this year that they will buy consumer internet businesses, as the 15 startup listings of 2026 so far suggest. A company whose shares trade only in New York is asking Indian investors, and Indian employees with stock options, to own something far from home. An Indian listing closes that gap.
The talent point deserves more weight than it usually gets. Stock that trades on NSE in rupees, under the same name as the company you work for, is easier to value and easier to sell than options in a foreign parent. When engineers compare offers, that difference shows up.
How the confidential route works
MakeMyTrip used SEBI's pre-filing route, which sits in Chapter IIA of the ICDR Regulations. A practitioner explainer from Corporate Professionals lays out the steps:
Confidential filing of a pre-filed draft with SEBI and the exchanges. The public doesn't see it.
A short public announcement within two working days, which must say that pre-filing "shall not necessarily mean that the issuer shall undertake the initial public offering."
Limited testing of interest with qualified institutional buyers while SEBI reviews.
SEBI's observations, which is the stage MMT India just reached.
UDRHP-I, an updated draft placed in public for at least 21 days of comments, followed by UDRHP-II.
The issuer then has 18 months from SEBI's observations to open the issue, provided UDRHP-I is filed within 16 months. One constraint matters for an all-OFS deal like this: if the OFS size changes by more than 50% after the confidential filing, the draft has to be refiled.
Why founders like it: if markets turn and the IPO is shelved, the detailed numbers never became public. Competitors don't get a free look at your margins, and a withdrawn IPO is less of a story.
What to look for when the public draft lands
Once UDRHP-I is out, it's worth reading with the method from our walkthrough of Zetwerk's prospectus. For a listed subsidiary of a listed parent, a few questions matter more than usual:
What sits inside MMT India, and what stays with the parent? Brands, technology, overseas businesses and intellectual property can live in different entities.
Related-party flows. Any fees, licences or shared costs between the Indian company and the parent decide how much profit stays with Indian minority shareholders.
Control. As long as the parent holds a majority, minority shareholders in India are along for the ride on big decisions.
Valuation gap. If Indian investors price MMT India very differently from how Nasdaq prices the whole group, that gap tells you a lot about where to list your own company.
Three takeaways for founders
Where you list is a long decision. A US listing made sense for an Indian internet company over 15 years ago. Today, the same company is building a second front door at home.
An OFS is a liquidity tool. If your early backers or a parent need an exit, an OFS gives them one without diluting anyone. It also means public investors are buying from insiders, so expect them to ask why the insiders are selling.
The confidential route buys optionality cheaply. You can get SEBI's comments, sound out institutions and still walk away quietly.
The size, price band and dates will come with the public draft. Until then, MMT India is worth watching less as a travel stock and more as a test of a structure that other India-heavy, foreign-listed companies may copy.



